List of products by brand Krishgen

Filter By
Reference: KBI1449
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Lupartumab Amadotin in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1450
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Lutikizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1452
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Magrolimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1454
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Mapatumumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1455
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Margetuximab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1456
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Marstacimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1460
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Mavrilimumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1461
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Meplazumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1466
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Minretumomab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1467
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Mirikizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1470
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Mirzotamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1472
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Mitazalimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1475
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Mogamulizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1476
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Monalizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1478
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Mosunetuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1480
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Moxetumomab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1482
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Murlentamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1483
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Muromonab-Cd3 in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1485
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Namilumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1490
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Narsoplimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1492
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Navicixizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1494
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Naxitamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1497
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Nemolizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1498
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Nerelimomab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1500
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Netakimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1502
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Nimacimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1503
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Nimotuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1504
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Nirsevimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1518
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Oleclumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1520
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Olinvacimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1521
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Olokizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1522
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Omburtamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1525
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Ontamalimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1528
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Opicinumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1530
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Oregovomab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1531
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Orilanolimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1532
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Orticumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1533
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Osocimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1535
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Otilimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1542
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Pamrevlumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1544
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Parsatuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1546
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Pasotuxizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1551
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Pepinemab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1555
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Pidilizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1556
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Pinatuzumab Vedotin in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1559
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Plamotamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1560
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Plozalizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1563
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Porgaviximab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1564
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Pozelimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1571
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Pritumumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1572
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Prolgolimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1573
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Quetmolimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1574
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Quilizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1580
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Ranevetmab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1581
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Ravagalimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1586
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Relatlimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1588
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Remtolumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1590
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Retifanlimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1597
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Roledumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1600
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Romilkimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1607
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Rozanolixizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1611
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Samalizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1612
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Samrotamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1615
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Sasanlimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1619
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Selicrelumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1620
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Semorinemab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1623
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Seribantumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1626
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Setrusumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1633
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Siplizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1636
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Sirukumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1642
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Spartalizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1647
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Sutimlimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1649
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Suvratoxumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1657
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tafolecimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1658
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Talacotuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1660
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tamrintamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1663
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tanezumab in serum and plasma. Lead Time 3 - 4 weeks.

Menu

Settings